TurnerTrends Stock Rating Report for ARIA
Data valid for week beginning October 06, 2008
|
ARIA [News]
|
Ariad Pharmaceuticals Inc
|
Company Profile
"ARIAD Pharmaceuticals, Inc., together with its subsidiaries, discovers and develops medicines to treat cancers by regulating cell signaling with small molecules in the United States and Europe. The company’s cancer product candidate includes deforolimus, a potent protein mTOR inhibitor for the treatment of solid tumors, such as sarcomas, hormone refractory prostate cancer, endometrial cancer, brain cancer, and leukemias and lymphomas. It offers Phase 3 clinical trial of oral deforolimus in patients with metastatic soft-tissue and bone sarcomas- and multiple clinical trials of deforolimus, including Phase 2 clinical trials in endometrial, breast, and prostate cancers. The company studies deforolimus as a single agent in multiple Phase 1 and Phase 2 clinical trials in patients with sarcomas, hormone refractory prostate cancer, endometrial cancer, brain cancer, and leukemias and lymphomas. It conducts various multi-center Phase 1b trials of deforolimus in combination with anti-cancer therapies, which focuses on patients with various types of solid tumors- and Phase 1 trials of AP24534 that is used in the treatment of drug-resistant and refractory chronic myeloid leukemia, and hematological cancers. The company licenses NF-kB cell-signaling technology and treatment methods to pharmaceutical and biotechnology companies that conducts research to discover and develop drugs that modulate NF-kB cell-signaling and-or marketing such drugs- and ARGENT cell-signaling regulation technology for various pharmaceutical and biotechnology companies for research and development of therapeutic vaccines, and gene and cell therapy. It has a license agreement with Medinol, Ltd. to develop and commercialize deforolimus-eluting stents and other medical devices to prevent restenosis or reblockage of injured vessels- and collaboration agreement with Merck & Co., Inc. to develop deforolimus. ARIAD Pharmaceuticals, Inc. was founded in 1991 and is based in Cambridge, Massachusetts."
|
Join today to see our Technical, Fundamental, and Composite Stock Rating for this stock.
|
|
|
Want to take a more "hands off" approach to investing with TurnerTrends? Try our managed accounts and hedge fund at Sabinal Capital Investments
|
|
Latest News
| Tue, 7 Oct 2008 20:31:07 Etc/GMT | ARIAD PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exh (EDGAR Online) | | Tue, 7 Oct 2008 11:30:00 Etc/GMT | Ariad Appoints Two New Members to Its Board of Directors (Business Wire) | | Mon, 6 Oct 2008 20:31:28 Etc/GMT | ARIAD PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits (EDGAR Online) | | Mon, 6 Oct 2008 11:30:00 Etc/GMT | ARIAD Announces Favorable Ruling Permitting Immediate Appeal of District Court Findings on NF-(kappa)B Patent in Amgen Litigation (Business Wire) | | Thu, 25 Sep 2008 10:28:09 Etc/GMT | Court Ruling Raises Concerns About Ariad's Conduct and Patents (at Seeking Alpha) | | Wed, 24 Sep 2008 14:44:45 Etc/GMT | Ariad's Lawsuit Loss and Investors' Gamble (at Motley Fool) | | Tue, 23 Sep 2008 21:22:28 Etc/GMT | ARIAD PHARMACEUTICALS INC Files SEC form 8-K, Other Events (EDGAR Online) | | Tue, 23 Sep 2008 18:25:43 Etc/GMT | Health Winners & Losers: ImClone (TheStreet.com) | | Mon, 22 Sep 2008 22:29:40 Etc/GMT | Movers roundup: Ariad Pharmaceuticals, US Bancorp (AP) | | Mon, 22 Sep 2008 20:46:54 Etc/GMT | ARIAD PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits (EDGAR Online) | | Mon, 22 Sep 2008 18:35:40 Etc/GMT | Ariad shares fall on unfavorable court decision (AP) | | Mon, 22 Sep 2008 11:30:00 Etc/GMT | ARIAD Announces Court Rulings Regarding NF-(kappa)B Patent Lawsuit with Amgen (Business Wire) | | Wed, 17 Sep 2008 20:38:22 Etc/GMT | ARIAD PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Ex (EDGAR Online) | | Fri, 12 Sep 2008 11:30:00 Etc/GMT | ARIAD Announces Merger with ARIAD Gene Therapeutics, Inc. (Business Wire) | | Tue, 2 Sep 2008 09:25:28 Etc/GMT | ARIAD Pharmaceuticals, Inc. Q2 2008 Earnings Call Transcript (at Seeking Alpha) | | Wed, 20 Aug 2008 13:04:19 Etc/GMT | ARIAD PHARMACEUTICALS INC Financials (EDGAR Online Financials) | | Mon, 11 Aug 2008 20:31:05 Etc/GMT | ARIAD PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report (EDGAR Online) | | Sat, 9 Aug 2008 13:21:19 Etc/GMT | New Star Analyst Rankings for ARIAD PHARM INC (StarMine) | | Thu, 7 Aug 2008 20:31:14 Etc/GMT | ARIAD PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Change in Directors or P (EDGAR Online) | | Thu, 7 Aug 2008 15:41:09 Etc/GMT | Earnings roundup: Fortress Investment, PMI (AP) | News provided by Yahoo! Finance |
|
